You can still catch the University of Illinois Cancer Center’s January segment on the popular show “Cafecito con Vicky” on WRLL 1450 AM.

You can still catch the Cancer Center’s January segment on WRLL 1450 AM, a Chicago Spanish-language radio station. It focused on #bloodcancers, and the guest was @uihealth.bsky.social Hematologist Carlos Galvez, MD.

Watch the segment here: https://bit.ly/4kgMOV4

Feel-Good Friday: Cancer Survivors, Stem-Cell Donors Share Emotional Meeting at 5K Run/Walk Event Cancer survivors share emotional meetings with their stem cell donors at a 5K run/walk event.

Weekend feels, on @RedState.

Feel-Good Friday: Cancer Survivors, Stem-Cell Donors Share Emotional Meeting at 5K Run/Walk Event redstate.com/jenniferoo/2... #FGF #FeelGoodFriday #StemCellDonors #SusanGKomen #StepsforLife #BocaRaton #Cancer #BloodCancers

Tune into WRLL 1450 AM, on Wednesday, January 28.

Tune into WRLL 1450 AM, on Wednesday, January 28, for the University of Illinois Cancer Center segment when they'll be talking about #bloodcancers and providing key information for the Latine Community.

The show starts at 10 a.m. CT.

Listen live here: https://bit.ly/4qCrJXA

Research co-led by MSK scientists found a gene variant that may reduce the risk of developing certain #bloodcancers associated with #clonalhematopoiesis. Learn more about how @mskcancercenter.bsky.social is leading the way in CH research and treatment.

Also check out our CH clinic: bit.ly/49szicf

Scientists have known for decades that there are gene mutations that increase your risk of developing cancer. But there is also a genetic variant that could reduce the risk of developing certain #bloodcancers, according to new research co-led by scientists from MSK.

Learn more: bit.ly/4sIJ5DQ

Excited to kick off 2026 with a #Hematology seminar from Arun Wiita, MD, PhD on Jan 8th! Arun has pioneered proteomics to characterize aberrantly expressed cell surface proteins in #bloodcancers, to identify novel targets for #immunotherapy, looking forward to this! @stanforddeptmed.bsky.social

📢Meet our Fellows

Nadya Christina joined #CarrerasPathfinders to pursue her PhD under the supervision of Dr Marcus Buschbeck at
@carrerasijc.bsky.social.

👩‍🔬Learn about Nadya carreraspathfinders.eu/doctoral-can...
🔬her project carreraspathfinders.eu/projects/dc14/

#MSCActions #bloodcancers #phd

📢Meet our Fellows

Hollie Bunce joined #CarrerasPathfinders to pursue her PhD under the supervision of Dr Vincenzo Calvanese at
@carrerasijc.bsky.social.
👩‍🔬Learn about Hollie carreraspathfinders.eu/doctoral-can...
🔬her project carreraspathfinders.eu/projects/dc13/

#MSCActions #bloodcancers #phd

📢Meet our Fellows

Galina Medvedeva joined #CarrerasPathfinders to pursue her PhD under the supervision of Dr Biola Javierre at @carrerasijc.bsky.social

👩‍🔬Learn about Galina carreraspathfinders.eu/doctoral-can...
🔬her project carreraspathfinders.eu/projects/dc12/

#MSCActions #bloodcancers #phd

📢Meet our Fellows

Niladri Koner joined #CarrerasPathfinders to pursue his PhD under the supervision of Dr Sergi Cuartero at @carrerasijc.bsky.social

👨‍🔬Learn about Niladri carreraspathfinders.eu/doctoral-can...
🔬his project carreraspathfinders.eu/projects/dc11/

#MSCActions #bloodcancers #phd

Imaging's Hidden Cost: There may be a link between #medical #imaging and childhood #BloodCancers. A retrospective cohort study found that 10.1% of #hematologic cancers in children may be caused by #radiation exposure from medical imaging.
#HemeSky #OncSky

BMS's Breyanzi is first CAR-T for marginal zone lymphoma Bristol Myers Squibb has taken CAR-T therapy into new territory, after getting FDA approval for Breyanzi in marginal zone lymphoma.

#BristolMyersSquibb has taken #CARTtherapy of #bloodcancers into new territory, after getting #FDAapproval for Breyanzi as a treatment for relapsed or refractory #marginalzonelymphoma (MZL).

pharmaphorum.com/news/bmss-br...

Delighted to welcome Dr. Fred Appelbaum from #FHCRC to Stanford #Hematology today! A giant in #bloodcancers, a superb #physicianscientist &
recently an author of the fab book #LivingMedicine, a history of Dr. Don Thomas, marrow transplant & #celltherapy, a great read!
@stanforddeptmed.bsky.social

Missed our #BloodCancers #OncTalk2025 event? 🎥
The full recording is now available on YouTube!
Watch here ⬇️
www.youtube.com/watch?v=6Anm...

#CancerGRACE #CancerEducation #OnDemand

How do I treat Lower-Risk MDS?
Dr. @AshKishtagari

#BloodCancers #LowerRiskMDS

Umoja's in vivo cell therapy fast-tracked by FDA A pioneer of in vivo cell therapy, Umoja has cleared another regulatory milestone by getting fast-track status for its lead blood cancer programme.

One of the pioneers of in vivo #celltherapy, #UmojaBiopharma, has cleared another regulatory milestone after getting a #fasttrackdesignation from the FDA for its lead candidate for #bloodcancers, partnered with #AbbVie.

Impact on Blood Cancer 01.10.2025 10:30 CET Online event Registration now open Meet the speakers Michael Hudecek, University Hospital Würzburg Jesús María Hernandez, University Hospital of Salamanca and ISBAL Sonja Steppan, Fresenius SE & Co, KGaA Lars Bullinger, Charité Universitätsmedizin Berlin Oussama Karroum, Innovative Health Initiative

🩸 From mining #BigData to advancing #CarTCell therapies, our projects are working hard to improve the lives of people living with #BloodCancers like leukaemia
👉 Find out more at our online event on 1 October - sign up at europa.eu/!hdYgBh
#IHITransformingHealth #HorizonEU

We are excited to announce #NDLR2026 speaker, Assoc Prof @LevKats from @PeterMacCC. Lev's research includes #Epigenetic regulation, #Metabolism and #TargetedTherapies. His lab uses molecular and functional #Genomics to develop new treatment strategies for aggressive #BloodCancers

Impact on Blood Cancer Leveraging big data and CAR-T therapies to improve outcomes for patients 10:30-12:00 CET 01.10.2025

🩸 How can we improve outcomes for people with #BloodCancers?
🚀 Leveraging #BigData, #AI and #CARTCell therapies, our projects are delivering important results for patients
👩‍💻 Join us online on 1 October find out more!
👉 europa.eu/!hdYgBh
#IHITransformingHealth #CellTherapy

Advancements in Blood Cancer Treatment by Florida Cancer Specialists at SOHO 2025 Florida Cancer Specialists showcase groundbreaking research on blood cancer treatments at SOHO 2025, emphasizing real-world evidence and clinical advancements.

Advancements in Blood Cancer Treatment by Florida Cancer Specialists at SOHO 2025 #USA #Houston #FloridaCancerSpecialists #BloodCancers #SOHO2025

Impact on Blood Cancers Leveraging big data and CAR-T therapies to improve outcomes for patients

🩸 How can we improve outcomes for people with #BloodCancers?
🚀 Leveraging #BigData, #AI and #CARTCell therapies, our projects are delivering results.
👩‍💻 Join us online on 1 Oct 10:30–12:00 CET & find out more!
europa.eu/!hdYgBh
#BigDataInHealth #IHITransformingHealth

Great to see call to action by @nmdp-org.bsky.social at our local bus stop in NYC. Register to be a stem cell transplant donor and save a life! #bmtsm #bloodcancers

📢Meet our Fellows

Simran Panda joined #CarrerasPathfinders to pursue her PhD under the supervision of Dr Anna Bigas at @carrerasijc.bsky.social.

👩‍🔬Learn about Simran carreraspathfinders.eu/doctoral-can...
and 🔬her project carreraspathfinders.eu/projects/dc10/

#MSCActions #bloodcancers #phd

📢Meet our Fellows

Emilio Ruini joined #CarrerasPathfinders to pursue his PhD under the supervision of Dr @belverlab.bsky.social at @carrerasijc.bsky.social.

👨‍🔬Learn about Emilio carreraspathfinders.eu/doctoral-can...
and his project carreraspathfinders.eu/projects/dc9/

#MSCActions #bloodcancers

📄 [Press release] – MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2025.

👉 For more information, read the full press release: www.maatpharma.com/june-19-2025...

#BloodCancers #Cancer #aGvHD #Microbiome #MAA #EMA #Oncology #GeneralMeeting #Xervyteg #Business

PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance PSGL-1 acts as a phagocytosis checkpoint to promote tumor immune escape through impeding LFA-1 activation in macrophages.

New in #Science #Immunology: Researchers at Sun Yat-Sen University in Guangzhou report that #BloodCancers expressing PSGL-1 can prevent the #integrin signaling #macrophages need for #phagocytosis. Targeting PSGL-1 improved survival in mouse models of #leukemia, #lymphoma, & #MultipleMyeloma!

📢Meet our Fellows

Isorchand Chongtham joined #CarrerasPathfinders to pursue his PhD supervised by Dr Sònia Guil
at @carrerasijc.bsky.social.

👨‍🔬Learn about Isorchand carreraspathfinders.eu/doctoral-can...
🔬about his project carreraspathfinders.eu/projects/dc7/

#MSCActions #bloodcancers

CAR T-cell therapy is potentially lifesaving for patients with #bloodcancers. The #CARTVision is to double the proportion of eligible patients treated with the curative potential of CAR T-cell therapy by 2030. Join us to help make this Vision a reality: bit.ly/3S7WeFl

Each day counts! ⏳

The #CarrerasLeaders #postdoc program is your chance to join @carrerasijc.bsky.social and drive innovative research in #bloodcancers.

Not sure about your eligibility or potential supervisors?

Just ask — we’re here to help.

Apply at carrerasleaders.eu

#MSCActions #postdocjobs